Skip to content

Postprandial Walking in Obese Pregnant Women and Perinatal Outcomes - a Multicenter Randomized Clinical Trial

Postprandial Walking in Obese Pregnant Women and Perinatal Outcomes - a Multicenter Randomized Clinical Trial

Status
Withdrawn
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02180152
Enrollment
0
Registered
2014-07-02
Start date
2015-03-31
Completion date
2016-03-31
Last updated
2020-07-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gestational Diabetes, Obesity, Preeclampsia

Keywords

Perinatal outcomes

Brief summary

The purpose of this study is to verify if postprandial walks are effective in obese pregnant women, as regards to gestational weight gain and typical diseases of that period, as gestational diabetes and preeclampsia. Perinatal outcomes will be observed, such as macrosomia, shoulder dystocia and fetal death.

Interventions

BEHAVIORALPostprandial walks

Obese pregnant women will be target to carry out walks lasting 10' after the main meals (breakfast, lunch and dinner), Monday to Friday, during 8 weeks. Adherence to the program will be determined by daily readings of pedometers previously provided to pregnant women; minimum of 1500 steps per day from Monday to Friday.

Sponsors

Professor Fernando Figueira Integral Medicine Institute
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 40 Years
Healthy volunteers
No

Inclusion criteria

* Age between 18 and 40 years; * Gestational age ≤ 20 weeks, calculated from the last menstrual period and confirmed by the first ultrasound scan; * Obesity - body mass index ( BMI ) ≥ 30 kg/m2, based on the weight before pregnancy, reported by pregnant women no more than 5 kg below measured at admission to the study; * Physically inactive - according to the International Physical Activity Questionnaire (IPAC); * Single pregnancy.

Exclusion criteria

* Kidney disease or collagen; * Previous history of GDM; * Diabetes type 1 or type 2; * Hypertensive disorders related to pregnancy; * Hemodynamic instability; * Vaginal bleeding; * Visual, auditory or cognitive impairment.

Design outcomes

Primary

MeasureTime frame
Weight gain after postprandial walks in obese pregnant women.8 weeks

Countries

Brazil

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026